Regulation of growth hormone expression by Delta-like protein 1 (Dlk1)

被引:32
作者
Ansell, Peter J.
Zhou, Yunli
Schjeide, Brit-Maren
Kerner, Alissa
Zhao, Jing
Zhang, Xun
Klibanski, Anne
机构
[1] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
Dlk1; growth hormone; promoter;
D O I
10.1016/j.mce.2007.04.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Delta-like protein 1 (Dlk1) is a transmembrane protein characterized by epidermal growth factor (EGF)-like repeats. Dlk1, which is also known as preadipocyte factor 1 (pref-1) because of its ability to inhibit preadipocyte differentiation, regulates the differentiation of several other cell types through unknown mechanisms. To elucidate DIM functions, identification of Dlk1-regulated target genes is critical. The observation that Dlk1 is expressed in many endocrine tissues suggests that Dlk1 may have endocrine-related functions. Because Dlk1 is expressed in GH producing cells, we hypothesize that one function of Dlk1 is to regulate GH expression. We found that GH mRNA, protein, and secretion were significantly decreased in GH3 pituitary cell clones that stably express Dlk1. In contrast, Dlk1 expression was unable to alter prolactin expression. Co-transfection of GH3 cells with a GH promoter-regulated reporter gene showed that Dlk1 repressed GH promoter activity. Deletion and mutation analysis of the GH promoter indicated that Pit-1 binding sites in the GH promoter are required for Dlk1-mediated repression. Furthermore, Dlk1 expression represses Pit-1-mediated transcription when both proteins are co-expressed in MCF-7 cells. Deletion analysis of Dlk1 revealed that the ability of Dlk1 to regulate GH promoter activity is independent of both its EGF-like repeats and its ability to modulate MAP kinase activity. The observation that Dlk1 regulates GH expression identifies the first endocrine function of Dlk1, establishes GH as a Dlk1-regulated target gene, and provides a model system to facilitate studies of Dlk1-mediated signaling. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 45 条
[1]   Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1 [J].
Abdallah, BM ;
Jensen, CH ;
Gutierrez, G ;
Leslie, RGQ ;
Jensen, TG ;
Kassem, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (05) :841-852
[2]   Identification of DLK1 variants in pituitary- and neuroendocrine tumors [J].
Altenberger, T ;
Bilban, M ;
Auer, M ;
Knosp, E ;
Wolfsberger, S ;
Gartner, W ;
Mineva, I ;
Zielinski, C ;
Wagner, L ;
Luger, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (03) :995-1005
[3]   Fetal antigen 1 in healthy adults and patients with pituitary disease: Relation to physiological, pathological, and pharmacological GH levels [J].
Andersen, M ;
Jensen, CH ;
Stoving, RK ;
Larsen, JB ;
Schroder, HD ;
Teisner, B ;
Hagen, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5465-5470
[4]   Thyroid hormones and the brain - Commentary [J].
Anderson, GW .
FRONTIERS IN NEUROENDOCRINOLOGY, 2001, 22 (01) :1-17
[5]   Repression of cancer protective genes by 17β-estradiol:: Ligand-dependent interaction between human Nrf2 and estrogen receptor α [J].
Ansell, PJ ;
Lo, SC ;
Newton, LG ;
Espinosa-Nicholas, C ;
Zhang, DD ;
Liu, JH ;
Hannink, M ;
Lubahn, DB .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 243 (1-2) :27-34
[6]   In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens [J].
Ansell, PJ ;
Espinosa-Nicholas, C ;
Curran, EM ;
Judy, BM ;
Philips, BJ ;
Hannink, M ;
Lubahn, DB .
ENDOCRINOLOGY, 2004, 145 (01) :311-317
[7]   Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency - A randomized, placebo-controlled trial [J].
Baum, HBA ;
Biller, BMK ;
Finkelstein, JS ;
Cannistraro, KB ;
Oppenheim, DS ;
Schoenfeld, AD ;
Michel, TH ;
Wittink, H ;
Klibanski, A .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) :883-+
[8]   Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/Delta-like protein in pancreatic islets: Molecular cloning and expression pattern during development and growth of the endocrine pancreas [J].
Carlsson, C ;
Tornehave, D ;
Lindberg, K ;
Galante, P ;
Billestrup, N ;
Michelsen, B ;
Larsson, LI ;
Nielsen, JH .
ENDOCRINOLOGY, 1997, 138 (09) :3940-3948
[9]   Does Fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation [J].
Floridon, C ;
Jensen, CH ;
Thorsen, P ;
Nielsen, O ;
Sunde, L ;
Westergaard, JG ;
Thomsen, SG ;
Teisner, B .
DIFFERENTIATION, 2000, 66 (01) :49-59
[10]   Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic β-cells:: possible physiological implications [J].
Friedrichsen, BN ;
Carlsson, C ;
Moldrup, A ;
Michelsen, B ;
Jensen, CH ;
Teisner, B ;
Nielsen, JH .
JOURNAL OF ENDOCRINOLOGY, 2003, 176 (02) :257-266